Evidence map›Paper›PMID 31664148›Full record

Observational studyScientific reports2019

Evaluating Glaucoma Treatment Effect on Intraocular Pressure Reduction Using Propensity Score Weighted Regression.

Mengfei Wu, Mengling Liu, Joel S Schuman, Yuyan Wang, Katie A Lucy, Hiroshi Ishikawa, Gadi Wollstein

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mengfei WuDepartment of Ophthalmology, New York University (NYU) School of Medicine, NYU Langone Health, New York, NY, USA.
Mengling LiuDepartment of Population Health, NYU School of Medicine, NYU Langone Health, New York, NY, USA. mengling.liu@nyulangone.org.
Joel S SchumanDepartment of Ophthalmology, New York University (NYU) School of Medicine, NYU Langone Health, New York, NY, USA.ORCID http://orcid.org/0000-0002-8885-3766
Yuyan WangDepartment of Population Health, NYU School of Medicine, NYU Langone Health, New York, NY, USA.
Katie A LucyDepartment of Ophthalmology, New York University (NYU) School of Medicine, NYU Langone Health, New York, NY, USA.
Hiroshi IshikawaDepartment of Ophthalmology, New York University (NYU) School of Medicine, NYU Langone Health, New York, NY, USA.
Gadi WollsteinDepartment of Ophthalmology, New York University (NYU) School of Medicine, NYU Langone Health, New York, NY, USA.
NYU Langone Health · US

Funding

Novel Glaucoma Diagnostics for Structure and Function - Renewal - 1R01EY013178 · NEI · WILLS EYE HEALTH SYSTEM · PI Joel S Schuman · 2000 to 2026
$17.5M
U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI) R01-EY013178
6 · The paper itself

Abstract

Observational studies in glaucoma patients can provide important evidence on treatment effects, especially for combination therapies which are often used in reality. But the success relies on the reduction of selection bias through methods such as propensity score (PS) weighting. The objective of this study was to assess the effects of five glaucoma treatments (medication, laser, non-laser surgery (NLS), laser + medication, and NLS + medication) on 1-year intraocular pressure (IOP) change. Data were collected from 90 glaucoma subjects who underwent a single laser, or NLS intervention, and/or took the same medication for at least 6 months, and had IOP measures before the treatment and 12-months after. Baseline IOP was significantly different across groups (p = 0.007) and this unbalance was successfully corrected by the PS weighting (p = 0.81). All groups showed statistically significant PS-weighted IOP reductions, with the largest reduction in NLS group (-6.78 mmHg). Baseline IOP significantly interacted with treatments (p = 0.03), and at high baseline IOP medication was less effective than other treatments. Our findings showed that the 1-year IOP reduction differed across treatment groups and was dependent on baseline IOP. The use of PS-weighted methods reduced treatment selection bias at baseline and allowed valid assessment of the treatment effect in an observational study.

Indexed as

Intraocular PressurePropensity ScoreAgedCombined Modality TherapyFemaleGlaucomaHumansMaleMiddle Aged

Identifiers

PMID31664148
PMCPMC6820863
OpenAlexW2982652779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.